These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17920539)

  • 1. Targeting MMPs in acute and chronic neurological conditions.
    Yong VW; Agrawal SM; Stirling DP
    Neurotherapeutics; 2007 Oct; 4(4):580-9. PubMed ID: 17920539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMPs in the central nervous system: where the good guys go bad.
    Agrawal SM; Lau L; Yong VW
    Semin Cell Dev Biol; 2008 Feb; 19(1):42-51. PubMed ID: 17646116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system.
    Toft-Hansen H; Babcock AA; Millward JM; Owens T
    J Neuroinflammation; 2007 Sep; 4():24. PubMed ID: 17883829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system.
    Gardner J; Ghorpade A
    J Neurosci Res; 2003 Dec; 74(6):801-6. PubMed ID: 14648584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.
    Zhang H; Chang M; Hansen CN; Basso DM; Noble-Haeusslein LJ
    Neurotherapeutics; 2011 Apr; 8(2):206-20. PubMed ID: 21455784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury.
    Esposito E; Genovese T; Caminiti R; Bramanti P; Meli R; Cuzzocrea S
    J Pineal Res; 2008 Sep; 45(2):149-56. PubMed ID: 18298463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TIMPs tango with MMPs and more in the central nervous system.
    Crocker SJ; Pagenstecher A; Campbell IL
    J Neurosci Res; 2004 Jan; 75(1):1-11. PubMed ID: 14689443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of matrix metalloproteinases in regulating neuronal disorder.
    Mukherjee A; Swarnakar S
    Mol Biol Rep; 2015 Jan; 42(1):1-11. PubMed ID: 25374425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMMPRIN, an upstream regulator of MMPs, in CNS biology.
    Kaushik DK; Hahn JN; Yong VW
    Matrix Biol; 2015; 44-46():138-46. PubMed ID: 25644103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators.
    Yong VW; Zabad RK; Agrawal S; Goncalves Dasilva A; Metz LM
    J Neurol Sci; 2007 Aug; 259(1-2):79-84. PubMed ID: 17382965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
    Baranger K; Rivera S; Liechti FD; Grandgirard D; Bigas J; Seco J; Tarrago T; Leib SL; Khrestchatisky M
    Prog Brain Res; 2014; 214():313-51. PubMed ID: 25410364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloproteinases, Neural Extracellular Matrix, and Central Nervous System Pathology.
    De Luca C; Papa M
    Prog Mol Biol Transl Sci; 2017; 148():167-202. PubMed ID: 28662822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The matrix metalloproteinases and CNS plasticity: an overview.
    Milward EA; Fitzsimmons C; Szklarczyk A; Conant K
    J Neuroimmunol; 2007 Jul; 187(1-2):9-19. PubMed ID: 17555826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis].
    Kurzepa J; Bartosik-Psujek H; Suchozebrska-Jesionek D; Rejdak K; Stryjecka-Zimmer M; Stelmasiak Z
    Neurol Neurochir Pol; 2005; 39(1):63-7. PubMed ID: 15735992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metalloproteinases and their associated genes contribute to the functional integrity and noise-induced damage in the cochlear sensory epithelium.
    Hu BH; Cai Q; Hu Z; Patel M; Bard J; Jamison J; Coling D
    J Neurosci; 2012 Oct; 32(43):14927-41. PubMed ID: 23100416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.
    Leppert D; Lindberg RL; Kappos L; Leib SL
    Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions.
    Maeda A; Sobel RA
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):300-9. PubMed ID: 8786388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and diseases of the CNS.
    Yong VW; Krekoski CA; Forsyth PA; Bell R; Edwards DR
    Trends Neurosci; 1998 Feb; 21(2):75-80. PubMed ID: 9498303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.